SEI Medical PCL (BKK:SEI)
Thailand · Delayed Price · Currency is THB 2.000
-0.060 (-2.91%)
At close: Oct 20, 2026
SEI Medical PCL Ratios and Metrics
Market cap in millions THB. Fiscal year is January - December.
Millions THB. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 19, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 340 | 371 | 677 | - | - | - | |
Market Cap Growth | -21.88% | -45.23% | - | - | - | - |
Enterprise Value | 346 | 252 | 580 | - | - | - |
Last Close Price | 2.00 | 2.08 | 3.65 | - | - | - |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 19, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 11.01 | 7.97 | 12.95 | - | - | - |
Forward PE | - | 5.42 | 12.15 | - | - | - |
PS Ratio | 0.83 | 0.82 | 1.52 | - | - | - |
PB Ratio | 1.10 | 1.19 | 2.40 | - | - | - |
P/TBV Ratio | 1.12 | 1.20 | 2.42 | - | - | - |
P/FCF Ratio | - | 9.95 | 17.07 | - | - | - |
P/OCF Ratio | - | 5.22 | 12.71 | - | - | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 19, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 0.84 | 0.56 | 1.31 | - | - | - |
EV/EBITDA Ratio | 6.10 | 3.53 | 7.49 | - | - | - |
EV/EBIT Ratio | 8.67 | 4.27 | 8.71 | - | - | - |
EV/FCF Ratio | - | 6.76 | 14.62 | - | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 19, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.43 | 0.32 | 0.34 | 1.55 | 3.22 | 0.43 |
Debt / EBITDA Ratio | 2.35 | 1.37 | 1.22 | 2.77 | 2.29 | - |
Debt / FCF Ratio | - | 2.71 | 2.44 | - | 2.64 | - |
Net Debt / Equity Ratio | 0.02 | -0.24 | -0.28 | 1.44 | 2.00 | 0.18 |
Net Debt / EBITDA Ratio | 0.12 | -1.06 | -1.00 | 2.74 | 1.55 | - |
Net Debt / FCF Ratio | -0.10 | -2.04 | -1.95 | -3.82 | 1.64 | - |
Asset Turnover | 0.81 | 0.92 | 1.16 | 1.35 | 1.20 | 1.48 |
Inventory Turnover | 1.84 | 2.06 | 2.10 | 1.93 | 1.72 | 2.35 |
Quick Ratio | 1.20 | 1.48 | 1.80 | 0.54 | 0.38 | 1.80 |
Current Ratio | 2.05 | 2.31 | 2.73 | 1.30 | 1.01 | 3.75 |
Return on Equity (ROE) | 10.30% | 15.66% | 28.94% | 40.65% | 21.81% | 11.44% |
Return on Assets (ROA) | 4.93% | 7.55% | 10.90% | 6.43% | 5.45% | 6.03% |
Return on Invested Capital (ROIC) | 10.58% | 21.28% | 26.76% | 17.10% | 15.00% | 10.27% |
Return on Capital Employed (ROCE) | 12.20% | 17.70% | 21.20% | 25.90% | 58.30% | 12.40% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 19, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 9.08% | 12.55% | 7.72% | - | - | - |
FCF Yield | -19.13% | 10.05% | 5.86% | - | - | - |
Dividend Yield | 5.50% | 5.05% | 3.02% | - | - | - |
Payout Ratio | 60.51% | 43.81% | - | 342.93% | 335.89% | - |
Buyback Yield / Dilution | -6.78% | -26.67% | -12.09% | -19.48% | -735.07% | - |
Total Shareholder Return | -1.28% | -21.62% | -9.08% | -19.48% | -735.07% | - |